Location: Home
  • search
  • go
  • Relate News
  • 6/6/2019Achaogen Disposes Most Assets to Cipla and Qilu thru Auction
  • 6/3/2019Upcoming Event: Measuring Business Impact & ROI
  • 6/3/2019Upcoming Event: Situational Training Needs Analysis
  • 5/31/2019Predicine Partners with FMD for Biomarker-Driven Trials and Regulatory...
  • 5/30/2019Upcoming Event: IDF World Congress 2019
  • 5/28/2019Top Ten Biologics by Batch Release Sales in China 2014-2018
  • 5/24/2019Upcoming Event: Extractables & Leachables China 2019
  • 5/24/2019Upcoming Event: 3rd International Conference on Obesity and Weight Los...
  • 5/24/2019Upcoming Event: The 4th Annual Biopharma Innovation Conference 2019
  • 5/23/2019GSK's Herpes Zoster Vaccine Shingrix Conditionally Approved in China
  • 5/17/2019NMPA Seeks Comments on Three Draft Documents on Drug/Vaccine Tracing D...
  • 5/17/2019China Proposes Major Changes to Pharmaceutical Regulations
  • 5/9/2019China Built 158 Internet Hospitals and Telemedicine Platforms in 19 Pr...
  • 5/8/2019Merck's Successful First Quarter Largely Driven by China Growth
  • 5/3/2019Immunomedics and Everest Medicines Announce License Agreement for Saci...
  • 4/30/2019Another Scandal Surfaces in China Involving Possibly Fake 9-valent HPV...
  • 4/29/2019NMPA Issues Two Technical Standards for Drug Tracing IT Platform
  • 4/29/2019NPC Solicits Public Comments on Amendment of the Drug Administration L...
  • 4/29/2019NPC Solicits Public Comments on Amendment of the Vaccine Management La...
  • 4/23/2019Hua Medicine Initiates First Combination Study of Dorzagliatin with SG...
  • 4/23/2019China's Legislature Begins Second Review of the Proposed Vaccine Manag...
  • 4/22/2019Lilly Announces Sale of Legacy Antibiotics Brands and Manufacturing Fa...
  • 4/22/2019Amendment of Drug Administration Law and Draft Vaccine Management Law ...
  • 4/22/2019China to Amend Healthcare Laws Relating to Physicians
  • 4/17/2019GSK CEO Pledges to Learn from Mistakes in the Booming Chinese Vaccine ...
  • 4/16/2019CStone Gains Chinese IND Approval for Avapritinib Phase I/II Bridging ...
  • 4/15/2019Hope Medicine Licenses Bayer's Human Antibody Targeting the PRL Recept...
  • 4/12/2019Luqa Pharma and Ferrer Enter Agreement for Antibiotic Ozenoxacin in G...
  • 4/10/2019Chongqing Zhifei Bio Halts Production after Delay in License Renewal
  • 4/10/2019Auction - Pharma Site Closure in XiAn, China (Bid Due by April 12)
  • Page:19/68 Total number of articles:2025: [First][<<] [17] [18] [19] [20] [21] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group